Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations

Documenti analoghi

• The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
  di: Ming Liu, et al.
  Pubblicazione: (2025)
• A 14‐Gene Panel for Predicting Colorectal Cancer Recurrence Using Circulating Tumor DNA in Different Testing Conditions
  di: Yuichi Hisamatsu, et al.
  Pubblicazione: (2025)
• Tumor‐Infiltrating Immune Cells Are More Abundant in Lung Metastases From Colorectal Cancer Than in Paired Primary Tumors and Their Prognostic Value Depends on Adjuvant Chemotherapy
  di: Danyil Kuznyecov, et al.
  Pubblicazione: (2026)
• Comprehensive Genome Profiling‐Initiated Tumor‐Informed Circulating Tumor DNA Monitoring for Patients With Advanced Cancer
  di: Taiga Sasaki, et al.
  Pubblicazione: (2025)
• Real‐World Adherence to Repeat Colorectal Cancer Screening With the Multi‐Target Stool DNA Test in a Large, Insured, and Average‐Risk Population
  di: Mallik Greene, et al.
  Pubblicazione: (2025)